Navigation Links
HDMA's Gray: Passage Of National Pharmaceutical Traceability Legislation A Critical Accomplishment For Healthcare Industry And Patients
Date:11/18/2013

ARLINGTON, Va., Nov. 18, 2013 /PRNewswire-USNewswire/ -- HDMA President and CEO John M. Gray released the following statement on the passage of national pharmaceutical traceability legislation (Drug Quality and Security Act/H.R. 3204) by the U.S. Senate.

"Today the Senate voted to establish a national traceability framework for prescription medicines. The federal preemption of state laws to further strengthen the U.S. pharmaceutical supply chain represents one of the most significant legislative accomplishments for our industry and, is especially important for the healthcare providers and pharmacies — and their patients — who count on the safe and efficient distribution of prescription medicines. Thanks to the commitment and hard work of the U.S. Congress, the 50-state patchwork of regulations will be replaced with one federal solution, ensuring the seamless movement and traceability of pharmaceuticals throughout the supply chain. This victory is the culmination of nearly a decade's worth of work by HDMA and all those who championed this issue. We applaud Congress for passing legislation to establish one national solution for a safer, more secure pharmaceutical supply chain, and urge President Obama to swiftly sign the bill into law."

Continue the conversation about federal pharmaceutical traceability on Twitter through the hashtag #1RxSolution.             

About HDMA
HDMA is the national association representing primary healthcare distributors, the vital link between the nation's pharmaceutical manufacturers and healthcare providers. Each business day, HDMA member companies ensure that 15 million prescription medicines and healthcare products are delivered safely and efficiently to nearly 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDMA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation's healthcare system. For more information, visit www.HealthcareDistribution.org.


'/>"/>
SOURCE Healthcare Distribution Management Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CHPA Applauds Alabama Senates Passage of Anti-Meth Bill
2. American Society of Hematology Statement on Senate Passage of Prescription Drug User Fee Act (PDUFA)
3. SOCMAs Bulk Pharmaceuticals Task Force Welcomes House Passage of FDA Reform Act
4. American Society of Hematology Statement on House Passage of Prescription Drug User Fee Act (PDUFA)
5. Statement from the Cystic Fibrosis Foundation on Passage of the EXPERRT Act in House of Representatives
6. Boston Scientific Commends Congress on Passage of Bill Reauthorizing Medical Device User Fees
7. Statement from the Cystic Fibrosis Foundation on Passage of the EXPERRT Act in the U.S. Senate
8. Medical Device Manufacturing Coalition Applauds Passage of Medical Device Tax Repeal Amendment
9. CHPA Applauds Governor Mike Pence and the Passage of SB 496
10. HDMA Statement On House Passage Of Federal Traceability Legislation
11. LaserLock Technologies Applauds the U.S. House Passage of the Drug Quality and Security Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market is ... Low drug registration cost in Latin American countries and continuous ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... 25, 2017 , ... Somnoware, a leading provider of digital ... module. Using this new feature, sleep physicians can now predict the likelihood of ... airway pressure (CPAP), oral, or other forms of sleep apnea therapy. The Somnoware ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in ... a special report in the May issue of Consumer Reports focused on heart health. ... for results achieved during and after coronary bypass and aortic valve replacement procedures. ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... instrument solutions, announces the continuation of its strategic partnership with and platinum sponsorship ... developing nations in the safe and effective management of complex spine deformity cases, ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s ... bundles, which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored with the ... the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I ... improve the lives of the poor and underserved in other parts of the world,” ...
Breaking Medicine News(10 mins):